Skip to content

Hyaluronic Acid and Polynucleotides in Ridge Preservation

The Use of Hyaluronic Acid and Polynucleotides in Ridge Preservation Sites Rehabilitated With a Complete Full Digital Workflow

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07099846
Acronym
P-005
Enrollment
40
Registered
2025-08-01
Start date
2025-06-09
Completion date
2028-05-31
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CAD-CAM, Hyaluronic Acid, Implant-supported Single Crowns, Socket Preservation

Keywords

alveolar ridge preservation, hyaluronic acid, polynucleotides, digital workflow, CAD-CAM, Implant rehabilitation

Brief summary

The aim of this study is to test the use of a bovine-derived bone graft combined with a polynucleotides-rich hyaluronic acid (PNHA) gel for the preservation of the bone after a tooth extraction (alveolar ridge preservation) and to test the performance of a fully-digital workflow to rehabilitate the site with a dental implant. 40 patients in need for a single tooth extraction will be recruited at Centro di Odontoiatria, Università di Parma and they will be randomly assigned to 2 groups: extraction and spontaneous healing or extraction and regeneration of the site with a bovine-derived bone graft combined with a PNHA gel. At 4 months after extraction an implant will be placed in the extraction site, which will be rehabilitated with a fully-digital workflow and patients will be followed up at up to 12 months post rehabilitation. Two 3D x-rays with a small field of view will be performed immediately after extraction and at 4 months post extraction to plan implant placement. These images will also be used to assess changes in the dimension of the post extraction bone (primary outcome). As part of the study different questionnaires will be administered to assess quality of life and perception of the therapy and the wound exudate in the area of the extraction will be collected non invasively with a collagen sponge to assess the expression of different proteins during the early healing days. On the day of implant placement a sample of bone tissue will also be collected as part of the bone drilling and histologically analysed.

Detailed description

This is a single-centre, double-blind RCT involving 40 patients in need for a single tooth extraction to be replaced with a dental implant. The study consists of 11 visits, over a minimum period of 20 months. Participants will be recruited at Centro di Odontoiatria, at Università di Parma amongst patients routinely seen in new patient clinics and follow-up clinics. After atraumatic tooth extraction, participants will be randomly allocated to one of the following treatment groups: - DBBM (Bio-oss, Geistlich) mixed with a PNHA gel (Regenfast, Mastelli) and socket sealed with a porcine collagen matrix (Mucograft seal, Geistlich) (Test); - Unassisted socket healing (Control). Patient post-operative discomfort will be assessed with a visual analogue scale (VAS) and through clinician-reported post-operative oedema/swelling. Clinical evaluation of socket healing and recording of soft tissue healing index of Landry will also be performed during the early post-extraction days. With the help of a sterilecollagen sponge, wound exudate will be collected at 3, 7 and 14 days post extraction. A CBCT with a small field of view (e.g. 5X8 cm) will be taken to assess the post-extraction socket dimensions and after 4 months to plan implant placement. The CBCT scan will be processed with its embedded segmentation function to remove scattering defects and obtain the maximal possible quality. Changes in alveolar ridge width from the extraction until 4 months post extraction between the 2 groups will be assessed with a dedicated software (e.g. SMOP) (primary outcome). On the day of implant placement, a bone core biopsy will be collected from the drilling site. Undecalcified histology analysis will be done, and qualitative histology will be performed by a blind examiner, who will assess the level of maturation of the tissue in the two groups. Moreover, histomorphometric measurements will be recorded and presented descriptively, including amount of mineralized bone, as well as other standard parameters, such as %graft particles (test group only) and % of immature woven bone. A fully digital workflow will be followed to rehabilitate the patients, which will be followed up at up to 12 months post implant loading.

Interventions

DEVICEregeneration of post extraction socket with biomaterials

after tooth extraction, in the test group we will place a demineralised bovine bone graft mixed with a gel containing hyaluronic acid and polynucleotide and we will cover the entrance of the socket with a collagen matrix

Sponsors

Geistlich Pharma AG
CollaboratorINDUSTRY
University of Parma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥25-year-old males and females; * good systemic health (self-assessment); * presence of an unrestorable/hopeless tooth with periodontal attachment and buccal bone preserved at least for 2/3rd of the root and not associated with acute periapical pathology; * full mouth bleeding and plaque scores ≤ 25%

Exclusion criteria

* uncontrolled or untreated periodontal disease; * history of local (head and neck) radiation therapy in the past 5 years; * acute endodontic lesion in the test tooth or in the neighbouring areas to the extraction procedure (sites with presence of an asymptomatic chronic lesion are eligible); * medical history that includes uncontrolled diabetes or hepatic or renal disease, or other serious medical conditions that can impact on bone metabolism (e.g. rheumatoid arthritis, osteoporosis) or transmittable diseases (e.g. HIV-related disease); * history of alcohol or drug abuse; * smokers of ≥10 cigarettes a day; * self-reported pregnancy or lactation.

Design outcomes

Primary

MeasureTime frameDescription
Change in alveolar ridge width at 4 months post extraction between study groups4 months after tooth extraction (visit 6)This is a superiority outcome evaluating horizontal ridge width changes at four months post-extraction between test and contro group with the help of a CBCT scan.

Secondary

MeasureTime frameDescription
Qualitative assessment of post-operative need for medicationsStarting after extraction (visit 2) and until 14 days post extraction (Visit 3, 4, 5)To record self-reported dosage and type of medications taken by the patients to control post operative pain in the test and control groups
quality of newly formed bone4 months post extraction (visit 6)to qualitatively assess socket healing and the maturity of the newly formed bone when DBBM combined with a PNHA and covered by a collagen matrix is employed for alveolar ridge preservation as compared to unassisted healing . A bone core biopsy will be taken at 4 months in both groups and the percentage of connective tissue, woven bone and mineralised bone calculated
3D volume changes4 months post extraction (visit 6)to assess 3D volume changes in soft and hard tissues at 4 and 12 months post extraction (this will be performed after digitally superimposing DICOM and STL files and in a selected region of interest) in the test and control groups
changes in protein expression3, 7 and 14 days post extraction (Visit 3, 4, 5)to assess and compare the expression of proteins and signalling pathways in the wound exudate at early healing stages. This will be done through full proteomic analysis via mass spectrometry of the wound exudate
Profilometric changes3, 7, 14 days and at 4 months post extraction (visit 3, 4, 5)to assess profilometric changes in the alveolar ridge via superimposition of intra oral scans of test and control groups
Changes in keratinized tissue4 months post extraction (Visit 6) and at study termination 12 months post loading (Visit 10);to assess changes in keratinized tissue (KT) height (measured in mm) in the area of the extraction (with the help of a periodontal probe) in the test and control groups
Change in Landry healing index3, 7 and 14 days after extraction (Visit 3, 4, 5)to assess changes in soft tissue healing index of Landry (qualitative index measured with a visual scale) in the test and control groups
Possibility to prosthetically place an implantimplant placement (Visit 7 - within 5 months from tooth extraction)To qualitatively describe the ability or not to place the implant in a prosthetically guided implant position with the endosteal portion of the implant completely in bone with more than 1-1.5 mm thickness on the buccal and oral aspect (Tonetti et al., 2023) (i.e. need for regeneration) at implant placement
Peri-implant radiographic bone level changesat implant loading (visit 9 - within 5 months from implant placement) and at the end of the study (12 months post loading - visit 10)To assess on peri-apical x-rays the changes in peri-implant bone levels (distance between bone crest and implant shoulder) in the 2 groups
Participants' satisfaction with treatmentat the end of the study, 12 months post loading (Visit 10)To qualitatively report participants' satisfaction via visual analogue scale (VAS) scale going from 0 (worse) to 10 (maximum positive effect)
Implant torqueImplant placement (visit 7 - within 5 months from tooth extraction)To qualitatively report implant torque, which is assessed with a torque wrench after surgically placing the implant and is measured in N/cm
Change in post operative discomfort3, 7 and 14 days after extraction (visit 3, 4, 5)to assess changes in patient post-operative discomfort, interference with daily activities and oedema and clinician-reported post-operative oedema/swelling via visual analogue scale (VAS) scale going from 0 (no effect) to 10 (maximum negative effect)

Countries

Italy

Contacts

Primary ContactElena Calciolari, DDS, MS, PhD
elena.calciolari@unipr.it+390521903640
Backup ContactFederico Rivara, DDS, MS, PhD
federico.rivara1@unipr.it+390521903640

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026